Trial Profile
Prospective clinical trial of autologous erythrocyte derived microparticles encapsulated methotrexate in the treatment of non-small cell lung cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2017
Price :
$35
*
At a glance
- Drugs Methotrexate (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 Aug 2017 New trial record